Pocket Guide to Chemotherapy Protocols

Front Cover
Jones & Bartlett Learning, 2007 - Medical - 179 pages
0 Reviews
A quick reference for physicians, nurses, and other healthcare providers treating cancer patents. The updated third edition of the Pocket Guide to Chemotherapy Protocols is spiral bound and arranged alphabetically by cancer type for easy access, and contains combination as well as selected single-agent regimens for solid tumors and hematologic malignancies. In each case, the regimens selected are based on the published literature and are used in clinical practice in the medical oncology community.
The Pocket Guide to Chemotherapy continues the success of previous editions by offering cancer care professionals complete, authoritative information in a convenient format.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Selected pages

Contents

Section 1
3
Section 2
8
Section 3
9
Section 4
10
Section 5
39
Section 6
41
Section 7
43
Section 8
51
Section 11
60
Section 12
61
Section 13
71
Section 14
75
Section 15
87
Section 16
114
Section 17
115
Section 18
120

Section 9
53
Section 10
58
Section 19
129
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page 172 - McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
Page 166 - Jr et al. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med 1972;76:227-234.
Page 174 - Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol.
Page 164 - Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992; 10:282-291.

Bibliographic information